Abstract: Metasurfaces can alter radar echo characteristics by dynamically modulating the phase of incident electromagnetic waves, thereby degrading radar signal processing performance. Recovering the ...
Ripples maintain time-locked occurrence across the septo-temporal axis and hemispheres while showing local phase coupling, revealing a dual mode of synchrony in CA1 network dynamics.
Abstract: Utilizing periodic phase modulation (PPM) can shift the echo spectrum, affecting matched filtering (MF) processing, leading to time delay shift or amplitude attenuation. The prior works on ...
Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics. These include photonic and quantum systems that could advance imaging, ...
Doing more with less in electronics often means improving power density. One of the new areas garnering attention involves applying a variety of advanced modulation techniques, including PWM and space ...
A one-slide representation is the best way to win over employees and investors. by João Cotter Salvado and Freek Vermeulen On December 1, 2014, Cypress Semiconductor announced that it was acquiring ...
Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CAS Complex modulation of optical fields (i.e., the control of light’s amplitude and phase) is vital to the ...
Picture yourself printing out this post to read later. Imagine the place you will sit while reading it. What do you see on the walls? What background sounds are in the room? Feel the weight and ...
Power Integrations has unveiled MotorXpert v3.0, a software suite for configuration, control and sensing of brushless DC inverters that utilize the company’s BridgeSwitch motor-driver ICs. The latest ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced MotorXpert™ v3.0, a software ...
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced completion of patient enrollment in the company’s Phase 2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback